Bioengineering & Biotechnology in Liver Diseases : NIDDK

Scientific Programs

Funding for Special Communities

To develop ways to improve the detection and characterization of liver and biliary disease and to aid in targeting therapies to these sites.

For more information, please see the Action Plan for Liver Diseases Research, or contact Dr. Jose Serrano, Director of the Liver and Biliary Program.

Dr. Kristin Abraham, Cell Signaling and Diabetes Centers Program Director
Dr. Guillermo Arreaza-Rubin, Director, Clinical Immunology, Type 1 Diabetes Program
Dr. Terry Bishop, Hematology Research Programs Director
Dr. Olivier Blondel, Director, Endocrine Systems Biology Program
Dr. Arthur Castle, Director, Metabolomics and Informatics Programs
Dr. Robert Karp, Director of the Genetics and Genomics Programs in Digestive Diseases and Nutrition
Dr. Maren Laughlin, Senior Advisor for Integrative Metabolism
Dr. Catherine McKeon, Senior Advisor for Genetic Research in Diabetes, Endocrinology and Metabolic Diseases
Dr. Marva Moxey-Mims, Kidney Centers Program Director; Pediatric Nephrology Program Director; Applied Kidney SBIR Program Director
Dr. Aaron Pawlyk, Director, Pharmacogenomics and Drug Discovery Program
Dr. Rebekah Rasooly, Deputy Director of the Division of Kidney, Urologic, and Hematologic Diseases
Dr. Salvatore Sechi, Proteomic Program Director
Dr. Jose Serrano, Director of the Liver and Biliary Program; Director of the Pancreas Program
Dr. Daniel Wright, Hematology Research Programs Director